Cargando…
Genomic and Transcriptomic Analysis for Identification of Genes and Interlinked Pathways Mediating Artemisinin Resistance in Leishmania donovani
Current therapy for visceral leishmaniasis (VL), compromised by drug resistance, toxicity, and high cost, demands for more effective, safer, and low-cost drugs. Artemisinin has been found to be an effectual drug alternative in experimental models of leishmaniasis. Comparative genome and transcriptom...
Autores principales: | Ghosh, Sushmita, Verma, Aditya, Kumar, Vinay, Pradhan, Dibyabhaba, Selvapandiyan, Angamuthu, Salotra, Poonam, Singh, Ruchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698566/ https://www.ncbi.nlm.nih.gov/pubmed/33213096 http://dx.doi.org/10.3390/genes11111362 |
Ejemplares similares
-
Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
por: Verma, Aditya, et al.
Publicado: (2017) -
Proteomic Analysis of Leishmania donovani Membrane Components Reveals the Role of Activated Protein C Kinase in Host-Parasite Interaction
por: Verma, Sandeep, et al.
Publicado: (2021) -
Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications
por: Gannavaram, Sreenivas, et al.
Publicado: (2014) -
Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress
por: Deep, Deepak Kumar, et al.
Publicado: (2017) -
Mitochondrial Associated Ubiquitin Fold Modifier-1 Mediated Protein Conjugation in Leishmania donovani
por: Gannavaram, Sreenivas, et al.
Publicado: (2011)